CanSense’s test is a blood-based assay that uses laser spectroscopy and artificial intelligence to identify early-stage colorectal cancer and precancerous polyps.
Keep Reading
Add A Comment
Trending
- Spyre raises $180m to advance IBD antibody pipeline (pharmaphorum)
- AI’s role in streamlining colorectal cancer screening (KevinMD.com)
- How United Digestive fared in 2023 (Becker’s GI & Endoscopy)
- Which GI groups are growing? (Becker’s GI & Endoscopy News)
- The Development of GI Psychology with Megan Riehl, PsyD (Healio)
- The 6 Biggest Stories in Medicine in 2023 (HCPLive)
- Eric Topol: Can AI catch what doctors miss? (TED Talks)
- AGA Clinical Practice Guideline Affirms Role of Biomarkers in Crohn’s Disease Management (Medscape)
